Phenylalanine

Mar 26, 2020

FDA Grants Orphan Drug Designation to APR-OD031 for the Treatment of Phenylketonuria (PKU)

Dec 24, 2019

Global & China D-Phenylalanine Ethyl Ester Market 2019 - Analysis and Forecast By Manufacturers, Product Type, Application, Regions and Technology - ResearchAndMarkets.com

Dec 03, 2019

Censa Pharmaceuticals Announces CNSA-001 Met Primary and Secondary Endpoints in Phase 2 Trial in Patients with PKU

May 06, 2019

European Commission Approves Palynziq® (pegvaliase injection) for Treatment of Phenylketonuria (PKU) in Patients Aged 16 Years or Older

Mar 01, 2019

BioMarin Receives Positive CHMP Opinion in Europe for Palynziq® (pegvaliase Injection) for Treatment of Patients with Phenylketonuria (PKU) Aged 16 and Older

Sep 07, 2018

China L-Phenylalanine Import Analysis Report 2018 - ResearchAndMarkets.com

Jul 05, 2018

Homology Medicines to Present at the National PKU Alliance Conference

May 24, 2018

FDA approves a new treatment for PKU, a rare and serious genetic disease

May 24, 2018

BioMarin Receives Standard Approval for Palynziq(TM) (pegvaliase-pqpz) Injection for Treatment of Adults with Phenylketonuria (PKU), a Rare Genetic Disease

May 18, 2018

Homology Medicines Presents Data from PKU Gene Therapy Program Demonstrating Long-Term Durability of Treatment in IND-Enabling Studies

Sep 05, 2017

BioMarin Announces 3 Platform and 15 Poster Presentations at 13th International Congress of Inborn Errors of Metabolism 2017